1162
Vol. 56, No. 8
OCOCH3*), 2.10 (1H, dd, 12.0, 4.5, H-1), 2.07 (1H, dd, 13.5, 8.0, H-15),
2.04 (3H, s, C-16-OCOCH3*), 1.86 (1H, ddd, 12.0, 5.0, 2.0, H-4ꢀ), 1.73 (1H,
q, 12.0, H-4ꢀ), 1.31 (3H, d, 6.5, H-6ꢀ), 1.29 (1H, t, 12.0, H-1), 1.20 (1H, td,
12.0, 3.0, H-9), 0.87 (3H, s, H-18).
lides and cardenolide glycosides without pregnane glyco-
sides. A marked difference in the constituents of this plant
was found between the aerial parts and roots. A. curassavica
is toxic, probably due to the cardenolides and their glyco-
19-Nor-10b-hydroxyasclepin (19): Amorphous powder. [a]D22 ꢁ22° (cꢂ
sides. We were interested in the cardiotoxicity and inhibitory 0.60, MeOH). FAB-MS m/z: 563 [MꢁH]ꢁ, 585 [MꢁNa]ꢁ. HR-FAB-MS
effect on Naꢁ–Kꢁ ATPase of these compounds.
m/z: 563.2854, 585.2676 (Calcd for C30H43O10: 563.2856 and C30H42O10Na:
585.2676). 13C-NMR (pyridine-d5 at 35 °C): shown in Table 1. 1H-NMR
(pyridine-d5 at 35 °C) d: 6.10 (1H, br t, 1.5, H-22), 5.42 (1H, dd, 12.0, 5.0,
H-3ꢀ), 5.27 (1H, dd, 18.5, 1.5, H-21), 5.25 (1H, s, C-14-OH), 5.18 (1H, s, C-
10-OH), 5.06 (1H, s, H-1ꢀ), 5.06 (overlapping, H-2), 5.01 (1H, dd, 18.5, 1.5,
H-21), 4.46 (1H, ddd, 12.0, 10.0, 4.5, H-3), 3.79 (1H, m, H-5ꢀ), 2.74 (1H,
dd, 9.0, 5.0, H-17), 2.47 (1H, dd, 12.0, 4.5, H-1), 2.17 (1H, td, 12.0, 3.0, H-
8), 2.10 (overlapping, H-4ꢀ), 1.99 (1H, q, 12.0, H-4), 1.97 (overlapping, H-
4ꢀ), 1.87 (3H, s, C-3ꢀ-OCOCH3*), 1.47 (1H, t, 12.0, H-1), 0.98 (3H, s, H-
18). 13C-NMR (CDCl3 at 35 °C) d: 174.3, 174.2 (C-20, -23), 172.3 (C-3ꢀ-
OC*OCH3), 117.8 (C-22), 96.1 (C-1ꢀ), 90.9 (C-2ꢀ), 85.0 (C-14), 75.7 (C-3ꢀ),
73.4 (C-21), 73.0 (C-10), 71.5 (C-3), 68.9 (C-2), 67.8 (C-5ꢀ), 50.7 (C-17),
49.4 (C-13), 48.0 (C-9), 43.4 (C-5), 41.1 (C-8), 39.6, 39.4 (C-1, -12), 35.5
(C-4ꢀ), 32.9 (C-15), 31.6 (C-4), 27.4 (C-6), 26.9, 26.5 (C-7, -16), 21.1 (C-3ꢀ-
OCOC*H3), 20.9 (C-6ꢀ), 20.7 (C-11), 15.7 (C-18). 1H-NMR (CDCl3 at
35 °C) d: 5.87 (1H, br t, 1.5, H-22), 4.97 (1H, dd, 18.0, 1.5, H-21), 4.79 (1H,
dd, 18.0, 1.5, H-21), 4.78 (1H, dd, 12.0, 5.0, H-3ꢀ), 4.59 (1H, s, H-1ꢀ), 4.22
(1H, ddd, 12.0, 10.5, 4.5, H-2), 3.97 (1H, td, 10.5, 6.0, H-3), 3.70 (1H, m, H-
5ꢀ), 2.76 (1H, dd, 9.5, 5.5, H-17), 2.14 (3H, s, C-3ꢀ-OCOCH3*), 2.10 (1H,
dd, 12.0, 4.5, H-1), 1.86 (1H, ddd, 12.0, 5.0, 1.5, H-4ꢀ), 1.73 (1H, q, 12.0, H-
4ꢀ), 1.59 (overlapping, H-8), 1.58 (overlapping, H-4), 1.38 (overlapping, H-
5), 1.28 (overlapping, H-1), 0.89 (3H, s, H-18).
Experimental
General Procedure The instrumental analysis was carried out as de-
scribed previously.27) Melting points were measured on a Yanaco MP-S3.
X-Ray Analysis Suitable colorless crystals of 20 were obtained by re-
crystallization (CHCl3–MeOH). The crystal (0.40ꢃ0.40ꢃ0.40 mm) be-
longed to the orthorhombic system, space group P212121(#19), with aꢂ
14.461(8) Å, bꢂ30.606(3) Å, cꢂ5.857(6) Å, Vꢂ2592(4) Å3, Zꢂ4. All meas-
urements were made on a Rigaku AFC7R diffractometer with graphite
monochromated CuKa radiation and a rotating anode generator. The struc-
ture was solved by direct methods28) and expanded using Fourier tech-
niques.29) The oxygen atom of the formyl group at C-19 adopted two posi-
tions, and the occupying parameters of this atom were also refined.
Plant Materials The aerial parts of Asclepias curassavica L. were col-
lected from the botanical garden of the University of Shizuoka in Japan in
September, 2001 and identified by Dr. T. Warashina. The dried materials
were stored in a herbarium.
Extraction and Isolation The dried aerial parts of Asclepias curassav-
ica L. (6.8 kg) were treated three times with MeOH under reflux. The extract
was concentrated under reduced pressure and the residue was suspended in
H2O. This suspension was extracted with Et2O. The H2O layer of the MeOH
extract was passed through a porous polymer gel (Mitsubishi Diaion HP-20)
column with the absorbed material being eluted with MeOH–H2O (1 : 1),
MeOH–H2O (7 : 3) and MeOH, respectively. The MeOH fraction from the
porous polymer gel column was then evaporated dry, with the residue
(13.7 g) subjected to silica gel CC with a CHCl3–MeOH (95 : 5—85 : 15)
system and semi-preparative HPLC (Develosil-ODS, and YMC-ODS: 27—
35% MeCN in water and 45—60% MeOH in water) to give compounds 1
(60 mg), 2 (5 mg), 3 (11 mg), 4 (8 mg), 5 (31 mg), 6 (6 mg), 7 (16 mg), 8
(3 mg), 9 (35 mg), 10 (21 mg), 11 (35 mg), 12 (4 mg), 13 (21 mg), 14
(42 mg), 15 (40 mg), 16 (8 mg), 17 (275 mg), 18 (16 mg), 19 (6 mg), 20
(9 mg), 21 (4 mg), 22 (28 mg), 23 (73 mg), 24 (6 mg), 25 (3 mg), 26 (4 mg),
27 (11 mg) and 28 (4 mg). However, compound 28 was not purified com-
pletely.
Calactinolactone (20): Prism from CHCl3–MeOH, mp 301—306 °C. [a]D22
ꢁ56° (cꢂ0.52, CHCl3–MeOH (1 : 1)). FAB-MS m/z: 531 [MꢁH]ꢁ. HR-
FAB-MS m/z: 531.2569 (Calcd for C29H39O9: 531.2594). 13C-NMR: shown
in Table 1. 1H-NMR (pyridine-d5 at 35 °C) d: 10.19 (1H, s, H-19), 6.11 (1H,
br t, 1.5, H-22), 5.63 (1H, s, H-1ꢀ), 5.56 (1H, td, 12.0, 5.0, H-2), 5.25 (1H,
dd, 18.0, 1.5, H-21), 5.00 (1H, dd, 18.0, 1.5, H-21), 4.52 (1H, dquint, 9.5,
6.0, H-5ꢀ), 3.93 (1H, td, 12.0, 4.0, H-3), 2.85 (1H, dd, 12.0, 5.0, H-1), 2.74
(1H, dd, 9.0, 5.0, H-17), 2.64 (1H, dd, 13.5, 9.5, H-4ꢀ), 2.61 (1H, dd, 13.5,
6.0, H-4ꢀ), 1.91 (1H, q, 12.0, H-4), 1.91 (overlapping, H-8), 1.73 (1H, dt,
12.0, 4.0, H-4), 1.40 (overlapping, H-5), 1.36 (3H, d, 6.0, H-6ꢀ), 1.23 (1H, t,
12.0, H-1), 0.92 (3H, s, H-18).
(8R,7ꢀS,8ꢀR)-5,5ꢀ-Dimethoxylariciresinol 9ꢀ-O-b-D-(6-O-E-4-Hydroxy-3-
methoxy-cinnamoyl)-glucopyranoside (23): Amorphous powder. [a]D22 ꢁ15.6°
MeOH
19-Dihydroasclepin (12): Amorphous powder. [a]D22 ꢁ17° (cꢂ0.37,
MeOH). FAB-MS m/z: 599 [MꢁNa]ꢁ. HR-FAB-MS m/z: 599.2806 (Calcd
for C31H44O10Na: 599.2832). 13C-NMR (pyridine-d5 at 35 °C): shown in
(cꢂ1.24, MeOH). UV l
nm (log e): 209 (4.71), 233 (4.26), 284 (sh),
max
299 (sh), 326 (4.12). FAB-MS m/z: 758 [M]ꢁ, 781 [MꢁNa]ꢁ. HR-FAB-MS
m/z: 758.2776 (Calcd for C38H46O16: 758.2786). 13C- and H-NMR: shown
1
1
in Table 2.
Table 1. H-NMR (pyridine-d5 at 35 °C) d: 6.10 (1H, br t, 1.5, H-22), 5.75
(8R,7ꢀS,8ꢀR)-5,5ꢀ-Dimethoxylariciresinol 9ꢀ-O-b-D-(6-O-Z-4-Hydroxy-3-
(1H, br t, 3.0, C-19-OH), 5.45 (1H, dd, 12.0, 5.0, H-3ꢀ), 5.28 (1H, dd, 18.5,
1.5, H-21), 5.08 (1H, s, H-1ꢀ), 5.01 (1H, dd, 18.5, 1.5, H-21), 4.90 (1H, ddd,
12.0, 11.0, 5.0, H-2), 4.46 (1H, td, 11.0, 5.0, H-3), 4.01 (1H, dd, 11.5, 3.0,
H-19), 3.79 (1H, m, H-5ꢀ), 3.74 (1H, dd, 11.5, 3.0, H-19), 2.94 (1H, dd,
12.0, 5.0, H-1), 2.76 (1H, dd, 9.0, 5.0, H-17), 1.78 (3H, s, C-3ꢀ-OCOCH3*),
1.37 (3H, d, 6.0, H-6ꢀ), 1.11 (1H, t, 12.0, H-1), 1.00 (3H, s, H-18).
methoxycinnamoyl)-glucopyranoside (24): Amorphous powder. [a]D22 ꢁ6.2°
MeOH
(cꢂ0.59, MeOH). UV l
nm (log e): 210 (4.67), 230 (sh), 282 (3.87),
max
324 (4.04). FAB-MS m/z: 758 [M]ꢁ, 781 [MꢁNa]ꢁ. HR-FAB-MS m/z:
781.2711 (Calcd for C38H46O16Na: 781.2684). 13C-NMR (MeOH-d4 at
35 °C) d: 168.1 (C-9ꢄ), 149.6 (C-4ꢄ), 148.4 (C-3ꢄ), 145.5 (C-7ꢄ), 128.1 (C-1ꢄ),
126.7 (C-6ꢄ), 116.2 (C-8ꢄ), 115.8 (C-5ꢄ), 115.3 (C-2ꢄ), 56.5 (-OMeꢄ). The
13C-NMR spectroscopic data of the aglycone and sugar moieties were in
good agreement with those of 23. 1H-NMR (MeOH-d4 at 35 °C) d: 7.68
(1H, d, 2.0, H-2ꢄ), 7.11 (1H, dd, 8.0, 2.0, H-6ꢄ), 6.80 (1H, d, 13.0, H-7ꢄ),
19-Nor-16a-acetoxy-10b-hydroxyasclepin (18): Amorphous powder. [a]D22
ꢁ
3.0° (cꢂ0.60, MeOH). FAB-MS m/z: 621 [MꢁH]ꢁ, 643 [MꢁNa]ꢁ. HR-
FAB-MS m/z: 621.2902 (Calcd for C32H45O12: 621.2911). 13C-NMR (pyri-
1
dine-d5 at 35 °C): shown in Table 1. H-NMR (pyridine-d5 at 35 °C) d: 6.28
6.75 (1H, d, 8.0, H-5ꢄ), 5.73 (1H, d, 13.0, H-8ꢄ), 4.49 (1H, dd, 12.0, 2.0, Hglc
-
(1H, br t, 1.5, H-22), 5.84 (1H, br s, C-14-OH), 5.68 (1H, td, 8.0, 4.0, H-16),
5.42 (1H, dd, 12.0, 5.0, H-3ꢀ), 5.29 (1H, s, C-10-OH), 5.29 (1H, dd, 18.0,
1.5, H-21), 5.17 (1H, dd, 18.0, 1.5, H-21), 5.07 (overlapping, H-2), 5.07
(1H, s, H-1ꢀ), 4.48 (1H, ddd, 11.5, 10.0, 4.0, H-3), 3.79 (1H, m, H-5ꢀ), 2.94
(1H, d, 4.0, H-17), 2.55 (1H, dd, 13.5, 8.0, H-15), 2.49 (1H, dd, 12.0, 4.5, H-
1), 2.22 (1H, td, 11.5, 3.0, H-8), 2.11 (1H, q, 12.0, H-4ꢀ), 2.09 (3H, s, C-3ꢀ-
OCOCH3*), 1.87 (3H, s, C-16-OCOCH3*), 1.50 (1H, t, 12.0, H-1), 1.39
(overlapping, H-5), 1.35 (3H, d, 6.5, H-6ꢀ), 1.00 (3H, s, H-18). 13C-NMR
(CDCl3 at 35 °C) d: 174.2 (C-23), 172.3 (C-3ꢀ-OC*OCH3), 171.0 (C-20),
170.7 (C-16-OC*OCH3), 118.4 (C-22), 96.2 (C-1ꢀ), 90.9 (C-2ꢀ), 84.7 (C-
14), 78.4 (C-16), 75.6 (C-3ꢀ), 73.8 (C-21), 73.0 (C-10), 71.5 (C-3), 68.9 (C-
2), 67.8 (C-5ꢀ), 57.8 (C-17), 48.8 (C-13), 47.9 (C-9), 43.5 (C-5), 40.9 (C-8),
39.7, 39.6 (C-1, -12), 39.3 (C-15), 35.5 (C-4ꢀ), 31.6 (C-4), 27.3 (C-6), 26.5
(C-7), 21.1, 21.0 (C-16-OCOC*H3, -3ꢀ-OCOC*H3), 20.9, 20.8 (C-11, -6ꢀ),
6), 4.31 (1H, dd, 12.0, 6.5, Hglc-6), 4.29 (1H, d, 8.0, Hglc-1), 3.83 (3H, s,
-
OMeꢄ), 3.50 (1H, m, Hglc-5), 3.38 (1H, t, 8.0, Hglc-3), 3.33 (1H, t, 8.0, Hglc-
4), 3.23 (1H, t, 8.0, Hglc-2). The 1H-NMR spectroscopic data of the aglycone
moiety were in good agreement with those of 23. But, the signals due to H-
7ꢀ and H-9ꢀ were observed as follows: d 4.80 (1H, d, 6.5, H-7ꢀ), 3.95 (1H,
dd, 10.0, 6.0, H-9ꢀ), 3.80 (overlapping, H-9ꢀ).
(8R,7ꢀS,8ꢀR)-5,5ꢀ-Dimethoxylariciresinol 9ꢀ-O-b-D-(6-O-E-4-Hydroxycin-
namoyl)-glucopyranoside (25): Amorphous powder. [a]D21 ꢁ18° (cꢂ0.26,
MeOH
MeOH). UV l
nm (log e): 207 (4.90), 222 (sh), 312 (4.26). FAB-MS
max
m/z: 751 [MꢁNa]ꢁ. HR-FAB-MS m/z: 751.2572 (Calcd for C37H44O15Na:
751.2578). 13C-NMR (MeOH-d4 at 35 °C) d: 169.0 (C-9ꢄ), 161.4 (C-4ꢄ),
146.8 (C-7ꢄ), 131.2ꢃ2 (C-2ꢄ, -6ꢄ), 127.0 (C-1ꢄ), 116.9ꢃ2 (C-3ꢄ, -5ꢄ), 114.9
1
(C-8ꢄ). H-NMR (MeOH-d4 at 35 °C) d: 7.57 (1H, d, 16.0, H-7ꢄ), 7.34 (2H,
1
d, 8.5, H-2ꢄ, -6ꢄ), 6.76 (2H, d, 8.5, H-3ꢄ, -5ꢄ), 6.28 (1H, d, 16.0, H-8ꢄ). The
13C- and 1H-NMR spectroscopic data of the aglycone and sugar moieties
were in good agreement with those of 23.
15.6 (C-18). H-NMR (CDCl3 at 35 °C) d: 5.94 (1H, br t, 1.5, H-22), 5.27
(1H, td, 8.0, 4.0, H-16), 4.92 (1H, dd, 18.0, 1.5, H-21), 4.85 (1H, dd, 18.0,
1.5, H-21), 4.79 (1H, dd, 12.0, 5.0, H-3ꢀ), 4.59 (1H, s, H-1ꢀ), 4.22 (1H, ddd,
12.0, 10.0, 4.5, H-2), 3.97 (1H, td, 10.0, 5.0, H-3), 3.70 (1H, m, H-5ꢀ), 2.64
(1H, d, 4.0, H-17), 2.25 (1H, dd, 13.5, 8.0, H-15), 2.15 (3H, s, C-3ꢀ-
(8R,7ꢀS,8ꢀR)-5,5ꢀ-Dimethoxylariciresinol 9ꢀ-O-b-D-(6-O-E-4-Hydroxy-
3,5-dimethoxycinnamoyl)-glucopyranoside (26): Amorphous powder. [a]D21